Results 161 to 170 of about 5,707,439 (181)
Some of the next articles are maybe not open access.
Microbiology Research
Tigecycline and the newly Food and Drug Administration-approved tetracyclines, including eravacycline and omadacycline, are regarded as last-resort treatments for multidrug-resistant Enterobacterales.
Yuqiao Han +10 more
semanticscholar +1 more source
Tigecycline and the newly Food and Drug Administration-approved tetracyclines, including eravacycline and omadacycline, are regarded as last-resort treatments for multidrug-resistant Enterobacterales.
Yuqiao Han +10 more
semanticscholar +1 more source
Tigecycline: The answer to beta-lactam and fluoroquinolone resistance?
Journal of Infection, 2006Patients with serious bacterial infections such as intra-abdominal infections and complicated skin and soft tissue infections are often treated empirically because a delay in appropriate initial antimicrobial therapy has been shown to significantly increase morbidity and mortality.
openaire +2 more sources
Tigecycline in the Era of Antibiotic Resistance: A Current Review
Current Medicinal ChemistryAbstract: Tigecycline (TIG) is a broad-spectrum antibiotic of the tetracycline class that evades the resistance mechanisms common to first- and second-generation tetracyclines and is effective against Gram-negative and Gram-positive bacteria, as well as intracellular bacteria.
Jessica L. Ortega-Balleza +5 more
openaire +2 more sources
Rapid Development of Acinetobacter baumannii Resistance to Tigecycline
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007A 53‐year‐old woman experienced a multidrug‐resistant (MDR) Acinetobacter baumannii urinary tract infection 5 months after undergoing kidney and liver transplantation. The tigecycline minimum inhibitory concentration (MIC) for her A. baumannii isolate was 1.5 μg/ml; the patient received 2 weeks of therapy with intravenous tigecycline as a 100‐mg ...
Gail E, Reid +4 more
openaire +2 more sources
[Resistance of Acinetobacter baumannii to Tigecycline].
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2019To determine the impact of long-term use of antibiotics and ultraviolet radiation on the resistance of Acinetobacter baumannii to tigecycline and the viability of tigecycline-resistant Acinetobacter baumannii .Three strains of tigecycline sensitive Acinetobacter baumannii were selected. Tigecycline resistance was induced through multi-step method or by
Jun-Yan, Qu, Xiao-Ju, Ü
openaire +1 more source
Bioessays, 2020
Antibiotic resistance in bacteria has become a great threat to global public health. Tigecycline is a next‐generation tetracycline that is the final line of defense against severe infections by pan‐drug‐resistant bacterial pathogens.
Liang-xing Fang +7 more
semanticscholar +1 more source
Antibiotic resistance in bacteria has become a great threat to global public health. Tigecycline is a next‐generation tetracycline that is the final line of defense against severe infections by pan‐drug‐resistant bacterial pathogens.
Liang-xing Fang +7 more
semanticscholar +1 more source
Oritavancin and Tigecycline: Investigational Antimicrobials for Multidrug‐Resistant Bacteria
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004The advent of multidrug‐resistant gram‐positive aerobes such as Staphylococcus aureus, Streptococcus pneumoniae , and the enterococci, which are resistant to β‐lactams, vancomycin, and a host of other commonly used antimicrobials, has complicated our approach to antibiotic therapy.
openaire +2 more sources
Microbial drug resistance (Larchmont, N.Y.), 2021
Tigecycline-resistant enterococci are only rarely detected worldwide. In 2017, the National Reference Centre for Staphylococci and Enterococci noticed a nosocomial cluster of tigecycline- and vancomycin-resistant Enterococcus faecium (TVRE) in a hospital of tertiary care in Northern Germany. Nineteen E.
Jennifer K, Bender +3 more
openaire +1 more source
Tigecycline-resistant enterococci are only rarely detected worldwide. In 2017, the National Reference Centre for Staphylococci and Enterococci noticed a nosocomial cluster of tigecycline- and vancomycin-resistant Enterococcus faecium (TVRE) in a hospital of tertiary care in Northern Germany. Nineteen E.
Jennifer K, Bender +3 more
openaire +1 more source